Agenda - India Pharma Summit

Transcription

Agenda - India Pharma Summit
 DepartmentofPharmaceuticals
MinistryofChemicalsandFertilizers
GovernmentofIndia
INDIAPHARMASUMMIT2014‐15
PolicyLandscapeReformsforStrengtheningIndianPharmaceuticalIndustry
“FocusonCriticalVerticalstoFosterAccesstoPharmaceuticals,EnhancingProductionand
TechnologyAdoptioninPharmaceuticalEnterprises&MedicalDevicesandDiagnostics”
23rdMarch,2015,HotelRamadaPlazaPalmGrove,JuhuBeach,Mumbai
DRAFTPROGRAMME
08:30‐09:30Hrs:Registration
09:30‐09:45Hrs:Seating
9:45‐11:00Hrs
09:45‐09:55Hrs
09:55‐10:05Hrs
10:05–10:15Hrs
10:15–10:25Hrs
10:25‐10:35Hrs
10:35‐10:50Hrs
10:50‐10:53HRS
10:53–11:00Hrs
11:00‐11:15Hrs
Inauguralsession
SessionModerator–Ms.ShobhaMishraGhosh,Sr.Director,FICCI
IntroductoryRemarks
Mr.SudhanshPant,JointSecretary,DepartmentofPharmaceuticals
OpeningAddress
DrNataMenabde,WHORepresentativetoIndia
SpecialAddress
DrHabilKhorakiwala,ChairmanFICCILifeSciencesCouncil,PastPresident
FICCIandChairmanWockhardtGroup
SpecialAddress
Mr.SatishReddy,Chairman,Dr.Reddy’sLaboratories
KeynoteAddress
Dr.VKSubburaj,Secretary,DepartmentofPharmaceuticals
InauguralAddress
ShriHansrajGangaramAhir,Hon’bleUnionMinisterforStatefor
Chemicals&Fertilizers
ReleaseofPositionPaper
ConcludingRemarks
Dr.ArbindPrasad,DirectorGeneral,FICCI
TeaBreak
DepartmentofPharmaceuticals
MinistryofChemicalsandFertilizers
GovernmentofIndia
11:15‐12:30Hrs
SessionI
Critical Verticalsto Foster AccesstoPharmaceuticalsat Nationaland
Internationallevels
Chair:DrV.K.Subburaj,Secretary,DepartmentofPharmaceuticals
Co‐Chair:Dr.M.ArizAhammed,JointSecretary,Departmentof
Pharmaceuticals
Presentationby:


12:30‐13:30Hrs
MrFransStobbelaar,Advisor,WHOIndiaCountryOffice
Mr Aditya Vijay Kumar Berlia, Co‐Chair FICCI Pharma Committee and
MemberManagementBoard,ApeejaySatya
Panelists:
 Mr.DGShah,SecretaryGeneral,IndianPharmaceuticalAlliance
 Mr.DaaraPatel,SecretaryGeneral,IDMA
 Mr.SudarshanJain,VicePresident,OPPIandManagingDirector,Abbott
IndiaLimited
LunchBreak
13:30‐14:50Hrs
SessionII
Promoting Production and Technology adoption in Pharmaceutical
EnterprisesforMeetingNationalandGlobalPublicHealthNeeds
Chair:Mr.RajivYadav,SpecialSecretaryandFinancialAdvisor,
DepartmentofPharmaceuticals
Co‐Chair:Mr.SudhanshPant,JointSecretary,Departmentof
Pharmaceuticals
Presentationby:
 DrMadhurGupta,TechnicalOfficer‐Pharmaceuticals,WHOIndia
CountryOffice
 Mr.RehanKhan,Co‐ChairFICCIPharmaCommitteeandManaging
Director,AbbottLimited
Panelists:
 DrManishaShridhar,RegionalAdvisor,TradeandHealth,WHOSEARO
 Mr S V Veeramani, President IDMA and Managing Director, Forturrs
Labs.Pvt.Ltd.
 Mr. Ashutosh Gupta, Chairman Pharmexcil and Managing Director,
DepartmentofPharmaceuticals
MinistryofChemicalsandFertilizers
GovernmentofIndia
MedicamenBiotechLimited.
14:50‐16:15Hrs
SessionIII
RegulatoryissuesandchallengesforMedicalDevicesandDiagnostics
Chair:Mr.AmitKhare,MemberSecretary,NPPA
Co‐Chair: Dr.S.EswaraReddy,DeputyDrugsController(lndia)
Presentationby:
 DrJoseeHansen,SeniorAdvisor,DepartmentofEssentialMedicines
andHealthProducts,WHOGeneva
 Mr.SushobhanDasgupta,ChairFICCIMedicalDeviceForumand
ManagingDirector,Johnson&JohnsonMedicalIndia
Panelists:
 Dr.G.S.Bhuvaneshwar‐Director,TrivitronHealthcarePvt.Ltd.
 Mr.AjayPitre,Co‐chairFICCIMedicalDevicesForumandManaging
Director,PitreBusinessVenturesPvt.Ltd.
 DrJitendraSharma,Head,DivisionofHealthcareTechnology,
NationalHealthSystemsResourceCentre,MinistryofHealth&
FamilyWelfare
TeaBreak
16:15‐16:30Hrs
16:30‐17:30Hrs
ValedictoryAddress
VisionStatementsby
 Mr.DilipShanghvi,ManagingDirector,SunPharma
 DrHabilKhorakiwala,ChairmanFICCILifeSciencesCouncil,Past
PresidentFICCIandChairmanWockhardtGroup
 DrNataMenabde,WHORepresentativetoIndia
 Mr.SudhanshPant,JointSecretary,DepartmentofPharmaceuticals
 Dr.M.ArizAhammed,JointSecretary,Departmentof
Pharmaceuticals
*ToBeConfirmed
20‐03‐2015